COVID‐19 in lung transplant recipients: A single‐center experience

Coronavirus disease 2019 (COVID‐19) is a global health problem. However, the course of this disease in immunosuppressed patients remains unknown. This study aimed to describe the course of COVID‐19 infection and its effects on lung transplant recipients.

[1]  Chris Stokel-Walker.  What we know about covid-19 reinfection so far , 2021, BMJ.

[2]  N. Holmes,et al.  Complete recovery from COVID-19 of a kidney-pancreas transplant recipient: potential benefit from everolimus? , 2021, BMJ Case Reports.

[3]  N. Nikitas,et al.  A case of COVID-19 reinfection in the UK. , 2020, Clinical medicine.

[4]  A. Elbendary,et al.  COVID-19 Mortality in Transplant Recipients. , 2020, International journal of organ transplantation medicine.

[5]  F. D'Ovidio,et al.  COVID-19 in lung transplant recipients: A single center case series from New York City , 2020, American Journal of Transplantation.

[6]  E. Múñez-Rubio,et al.  A Retrospective Controlled Cohort Study of the Impact of Glucocorticoid Treatment in SARS-CoV-2 Infection Mortality , 2020, Antimicrobial Agents and Chemotherapy.

[7]  G. Criner,et al.  COVID‐19 in lung transplant recipients , 2020, Transplant infectious disease : an official journal of the Transplantation Society.

[8]  F. Blasi,et al.  COVID‐19 in lung transplant recipients: A case series from Milan, Italy , 2020, Transplant infectious disease : an official journal of the Transplantation Society.

[9]  G. Hripcsak,et al.  Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19 , 2020, The New England journal of medicine.

[10]  N. Uriel,et al.  COVID-19 in solid organ transplant recipients: Initial report from the US epicenter , 2020, American Journal of Transplantation.

[11]  Antonio Romanelli,et al.  Immunosuppression drug-related and clinical manifestation of Coronavirus disease 2019: A therapeutical hypothesis , 2020, American Journal of Transplantation.

[12]  F. Diekmann,et al.  Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation? , 2020, American Journal of Transplantation.

[13]  Sharukh Lokhandwala,et al.  Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. , 2020, JAMA.

[14]  Hanxiong Guan,et al.  Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression , 2020, American Journal of Transplantation.

[15]  M. Mehra,et al.  COVID-19: Yet another coronavirus challenge in transplantation , 2020, The Journal of Heart and Lung Transplantation.

[16]  Alexis Jacquier,et al.  Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study , 2020, Travel Medicine and Infectious Disease.

[17]  P. Mehta,et al.  COVID-19: consider cytokine storm syndromes and immunosuppression , 2020, The Lancet.

[18]  G. Verleden,et al.  Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment-A consensus report from the Pulmonary Council of the ISHLT. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[19]  J. Fishman.  Infection in Organ Transplantation , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.